PPARγ is a key regulator of insulin sensitivity and can improve T2D through various mechanisms, such as increasing serum adiponectin levels, inhibiting inflammation, reducing mitochondrial reactive oxygen species production and promoting mitochondrial biosynthesis34. Here, ADIPOQ is linked to type 2 diabetes mellitus.